-
20 Mar 2026
From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan
-
20 Mar 2026
From the helm: Clarity Pharma (ASX:CU6), Chair, Alan Taylor & Senior Bell Potter Analyst John Hester
-
20 Mar 2026
From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.
-
20 Mar 2026
From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
-
20 Mar 2026
From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.
-
20 Mar 2026
From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.
-
20 Mar 2026
From the helm: Mesoblast (ASX:MSB), Director, Silviu Itescu
-
20 Mar 2026
From the helm: 4DMedical (ASX:4DX), Founder & CEO, Andreas Fouras.
-
20 Mar 2026
From the helm: EBR Systems (ASX:EBR), President & CEO, John McCutcheon
-
20 Mar 2026
Weekly Wrap 20 March
-
13 Mar 2026
Weekly Wrap 13 March
-
12 Mar 2026
Morning Bell - Max Lo Certo
